NAS:MESO (Australia)  
Mesoblast Ltd logo

Mesoblast Ltd

$ 2.79 -0.0126 (-0.45%) 10:11 AM EST
P/E:
At Loss
P/B:
0.78
Market Cap:
$ 411.67M
Enterprise V:
$ 460.40M
Volume:
5.20K
Avg Vol (2M):
74.88K
Also Trade In:
Volume:
5.20K
Market Cap $:
411.67M
PE Ratio:
At Loss
Avg Vol (2-Month):
74.88K
Enterprise Value $:
460.40M
PB Ratio:
0.78
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.
Name Current Vs Industry Vs History
Cash-To-Debt 0.56
Equity-to-Asset 0.75
Debt-to-Equity 0.22
Debt-to-EBITDA -1.5
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.29
Distress
Grey
Safe
Beneish M-Score -2.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.04
9-Day RSI 35.17
14-Day RSI 40.49
6-1 Month Momentum % -29.98
12-1 Month Momentum % -53.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.36
Quick Ratio 1.36
Cash Ratio 1.17
Days Sales Outstanding 100.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.5

Financials (Next Earnings Date:2022-11-23 Est.)

MESO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MESO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.211
EPS (TTM) ($) -0.704
Beta 4.02
Volatility % 72.34
14-Day RSI 40.49
14-Day ATR ($) 0.168627
20-Day SMA ($) 2.9945
12-1 Month Momentum % -53.65
52-Week Range ($) 2.14 - 7.275
Shares Outstanding (Mil) 147.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mesoblast Ltd Filings

Document Form Filing Date
No Filing Data

Mesoblast Ltd Analysis

Share your research

Headlines

See More
No news.